These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Kinase patent space visualization using chemical replacements. Southall NT; Ajay J Med Chem; 2006 Mar; 49(6):2103-9. PubMed ID: 16539399 [TBL] [Abstract][Full Text] [Related]
3. Patenting adverse event information: a commentary from the patent law. Wagner RP Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):396-7. PubMed ID: 16739247 [No Abstract] [Full Text] [Related]
4. [Patent protection of drugs, but how far?]. Teunissen HP Pharm Weekbl; 1966 Apr; 101(16):375-80. PubMed ID: 5932394 [No Abstract] [Full Text] [Related]
5. Ownership of knowledge--the role of patents in pharmaceutical R&D. Correa CM Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801 [TBL] [Abstract][Full Text] [Related]
6. Reference pricing of pharmaceuticals. Brekke KR; Königbauer I; Straume OR J Health Econ; 2007 May; 26(3):613-42. PubMed ID: 17188769 [TBL] [Abstract][Full Text] [Related]
7. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States. Miller CP; Ullrich JW Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591 [TBL] [Abstract][Full Text] [Related]
8. Protecting new ideas and inventions in nanomedicine with patents. Bawa R; Bawa SR; Maebius SB; Flynn T; Wei C Nanomedicine; 2005 Jun; 1(2):150-8. PubMed ID: 17292072 [TBL] [Abstract][Full Text] [Related]
9. The academic advantage: gender disparities in patenting. Sugimoto CR; Ni C; West JD; Larivière V PLoS One; 2015; 10(5):e0128000. PubMed ID: 26017626 [TBL] [Abstract][Full Text] [Related]
10. Enhanced funding of pharmacoepidemiology through patenting the disclosure of adverse event information. Classen JB Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):390-3. PubMed ID: 16411171 [TBL] [Abstract][Full Text] [Related]
11. Patent filing strategies for pharmaceuticals in Europe. Höpfner S Pharm Pat Anal; 2014; 3(6):563-5. PubMed ID: 25489909 [No Abstract] [Full Text] [Related]
12. Reaching a milestone in pharmaceutical patenting in Brazil. Blasi GD Pharm Pat Anal; 2018 Nov; 7(6):229-233. PubMed ID: 30632452 [No Abstract] [Full Text] [Related]
13. Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney. Melethil S AAPS J; 2005 Oct; 7(3):E723-8. PubMed ID: 16353948 [TBL] [Abstract][Full Text] [Related]
14. [Farmdoc coding system (Derwent) and pharmaceutical patent research]. Bocková H; Urbánková I; Königová M Cesk Farm; 1972 Feb; 21(1):18-22. PubMed ID: 5013312 [No Abstract] [Full Text] [Related]